Calcium phosphate particles as mucosal adjuvants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20020068090A1
SERIAL NO

09932538

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to mucosal immune protection, mucosal vaccine delivery, and mucosal drug delivery. Novel calcium phosphate core particles, particularly nanoparticles are used as vaccine adjuvants and compositions for inducing protective mucosal immunity. Methods of inducing an immune response to an antigen by delivering the antigen to a mucosal surface using the particles of this invention, and to methods of making such particles are also provided. The particles of this invention are also useful for delivering compositions, such as a pharmacologically active agent, to the mucosal surfaces of a patient in need thereof, to methods of delivering such compositions, and to methods of making such particles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CAPTIVATE PHARMACEUTICALS LLC3805 OLD EASTON ROAD DOYLESTOWN PA 18902

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bell, Steve J D Marietta, GA 6 144
He, Qing Atlanta, GA 166 2901

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation